New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 19, 2012
06:14 EDTJNJ, BCS, DB, LYG, STD, JPM, DOW, AEG, RY, ING, RIMM, CS, UBS, BBVA, RBSOn the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: Europe's program to defuse its financial crisis by injecting cash into the banking system is running out of energy as interest rates rise and some banks have little cash left, the Wall Street Journal reports...Dow Chemical (DOW) and other chemical companies see new opportunities in the enormous domestic deposits of gas, the Wall Street Journal reports...REUTERS: U.S. coal exports to China could more than double to over 12M tons in 2012 due to depressed freight rates and a decline in U.S. demand, says Xcoal Energy & Resources CEO Thrasher, Reuters reports...Johnson & Johnson (JNJ) received EU clearance to purchase Swiss medical device maker Synthes for about $21B, Reuters reports...BLOOMBERG: Research In Motion (RIMM) is close to deciding on a financial adviser, and JPMorgan Chase (JPM) is said to be the leading candidate to help the company weigh strategy options, Bloomberg reports.
News For STD;RBS;ING;LYG;BBVA;RY;DB;UBS;AEG;BCS;CS;DOW;JNJ;RIMM;JPM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 19, 2015
10:00 EDTDBOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aerie Pharmaceuticals (AERI) upgraded to Buy from Hold at Canaccord... Amedisys (AMED) upgraded to Buy from Hold at Jefferies... Consolidated Edison (ED) upgraded to Hold from Sell at Evercore ISI... Delta Air Lines (DAL) upgraded to Outperform from Peer Perform at Wolfe Research... Deutsche Bank (DB) upgraded to Neutral from Underperform at Exane BNP Paribas... EP Energy (EPE) upgraded on better than expected well economics at SunTrust... Encana (ECA) upgraded to Outperform from Market Perform at BMO Capital... Energy Transfer Partners (ETP) upgraded to Buy at BofA/Merrill... Erickson (EAC) upgraded to Outperform from In-Line at Imperial Capital... Fiserv (FISV) upgraded on growth opportunities, margin outlook at Oppenheimer... IPC Healthcare (IPCM) upgraded to Buy from Hold at Jefferies... Mack-Cali Realty (CLI) upgraded on valuation at Stifel... Micron (MU) upgraded to Buy on sustainable margins and capex at Topeka... NuStar Energy (NS) upgraded to Buy from Neutral at BofA/Merrill... NuStar GP Holdings (NSH) upgraded to Buy from Neutral at BofA/Merrill... Ramco-Gershenson (RPT) upgraded to Outperform from Neutral at Baird... Retail Opportunity (ROIC) upgraded to Outperform from Market Perform at Raymond James... Royal Dutch Shell (RDS.A) upgraded to Outperform from Sector Perform at RBC Capital... Smith & Wesson (SWHC) upgraded to Outperform from Sector Perform at RBC Capital... Sovran Self Storage (SSS) upgraded to Buy from Hold at Cantor... Springleaf (LEAF) upgraded to Outperform from Neutral at Macquarie.
07:02 EDTDBCanadian Solar receives $58M construction loan from Deutsche Bank
Subscribe for More Information
05:54 EDTRBSRBS looks to hire banker who had worked on ABN deal, Financial Times reports
Subscribe for More Information
05:32 EDTDBDeutsche Bank upgraded to Neutral from Underperform at Exane BNP Paribas
Subscribe for More Information
June 18, 2015
10:51 EDTRBSRBS close to returning 'missing' customer payments, The Telegraph says
Subscribe for More Information
07:50 EDTUBS, CSSNB pushes UBS, Credit Suisse to improve leverage ratios
Subscribe for More Information
07:28 EDTRBS, BCS, LYGLloyds CEO to call on U.K. banks to welcome ringfencing rules, Reuters says
Subscribe for More Information
06:21 EDTBCSFour banks to pay nearly $1B to settle forex rigging suit, AFP reports
Goldman Sachs (GS), BNP Paribas (BNPQY), Barclays (BCS), and HSBC (HSBC) have all reached separate agreements to settle a U.S. civil lawsuit over alleged foreign exchange rigging in deals totaling approximately $1B, AFP reports, citing sources close to the situation. The agreements are preliminary and are subject to change, the sources told AFP, confirming an earlier report on the settlements from the Wall Street Journal. Barclays is expected to pay $375M, HSBC $285M, BNP Paribas roughly $200M, and Goldman Sachs about $130M, the report says.The four banks' pending agreements would settle the civil lawsuit filed by Scott & Scott and Hausfeld that claims their traders manipulated the forex market to boost the banks' profits, AFP reports. Reference Link
06:01 EDTBCSBanks to settle civil forex lawsuit for nearly $2B, WSJ reports
Subscribe for More Information
June 17, 2015
17:37 EDTUBSGM hires advisers as Fiat Chrysler tries to force merger talks, Reuters says
Subscribe for More Information
14:55 EDTJPMJPMorgan announces unexpected death of Vice Chairman Jimmy Lee
Subscribe for More Information
11:16 EDTJPMOCC restricts some banks from certain mortgage related business activity
Subscribe for More Information
07:21 EDTJNJGeneric ADHD drugs still sold despite FDA non-equivalance finding, NYT reports
The FDA announced last November that two generic versions of Johnson & Johnson's (JNJ) Concerta ADHD drug, one made by Mallinckrodt (MNK) and the other by UCB, could no longer be considered the equivalent of the branded drug after tests and analyses suggested that their effectiveness began to wear off much more quickly, but the drugs are still being sold despite an FDA mandated deadline having passed for the companies to either prove the drugs were equivalent or remove them from the market, said The New York Times. The report noted a third generic product, sold by Actavis (AGN), was found to be equivalent to the branded Concerta. Reference Link
06:48 EDTJPMMore big banks waiving overdraft fees, WSJ reports
Subscribe for More Information
05:33 EDTAEGAEGON announces share repurchase to neutralize stock
Shareholders were given the opportunity to choose between receiving the 2014 final dividend of EUR 0.12 per common share in cash or in stock. 42% of shareholders elected to receive the stock dividend. Those who elected for a stock dividend will receive one Aegon common share for every 55 common shares held. The stock fraction is based on Aegon's average share price as quoted on Euronext Amsterdam, using the high and low of each of the five trading days from June 8 up to and including June 12, 2015. The average share price calculated on this basis amounted to EUR 6.62. The stock dividend and the cash dividend are approximately equal in value. Aegon will repurchase 16.28M common shares to neutralize the dilutive effect of the 2014 final stock dividend. These shares will be held as treasury shares and will be used to pay future stock dividends. Aegon is committed to the repurchase of the common shares by engaging a third party to execute the transactions on its behalf. These transactions will commence on June 17, and are expected to be completed on or before July 14. The common shares will be repurchased at a maximum of the daily volume-weighted average price. Aegon will provide weekly updates regarding the transactions on aegon.com/sharebuyback.
June 16, 2015
18:33 EDTJPMJPMorgan shareholder suit over 'London Whale' dismissed, Reuters reports
Subscribe for More Information
08:02 EDTDOWDow Chemical and Olin announce achievement of milestone
Subscribe for More Information
08:01 EDTDOWDow Chemical, Olin announce expiration of HSR waiting period
The Dow Chemical Company (DOW) and Olin Corporation (OLN) announced the achievement of a regulatory milestone in the proposed transaction involving a significant portion of Dow’s chlorine value chain and Olin Corporation, with the expiration of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. “This important milestone marks progress toward the close of a seminal transaction maximizing return for both Dow and Olin shareholders and the advancement of Dow’s targeted market participation and portfolio transformation strategies,” said Andrew N. Liveris, Dow’s chairman and CEO.As previously announced on March 27, Dow and Olin entered into a definitive agreement under which Dow will separate its U.S. Gulf Coast Chlor-Alkali and Vinyl, Global Chlorinated Organics and Global Epoxy businesses, and then merge these businesses with Olin in a Reverse Morris Trust transaction. The merger will result in Dow shareholders receiving at least a majority of the shares of Olin, with existing Olin shareholders owning the remaining shares. The transaction is expected to close by the end of the year and is subject to approval by Olin shareholders and completion of customary closing conditions.
07:11 EDTJPMSurprise AIG ruling may make future bailouts unlikely, even if needed, NYT says
Subscribe for More Information
06:19 EDTJPMJPMorgan, HSBC could move parts of businesses to Luxembourg, U.K. Times reports
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use